Shopping Cart 0
Cart Subtotal
AED 0

Worldwide Molecular Diagnostics Market Trends and Drivers, Restraints, and Opportunities 2017-2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12845

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 14680

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 16515
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Molecular Diagnostics Market-Drivers, Opportunities, Trends, and Forecasts: 2017-2023

Overview: Molecular diagnostics includes the measurement and analysis of nucleic acids, proteins, and metabolites to study the genotypes and occurrence of any biochemical changes in the body. This is mainly used to examine disease occurrence in blood, tissue, or even in the bones. The importance of DNA in defining the vital cellular process has facilitated medical advancements in different disease diagnosis. The detection of cancer and various infectious diseases at an early stage is an important advantage of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in front line.

The market for molecular diagnostics is driven by the increasing prevalence of infectious diseases, growing adoption of point-of-care testing, increasing demand for biomarker-based test, and high growth of the market in emerging countries. The growing significance of companion diagnostics, increased number of M&A, and the increased adoption of DNA probe-based diagnostics are providing market growth opportunities. However, stringent regulatory approval and lack of skilled labors are hampering the market growth.

Market Analysis: The Global Molecular Diagnostics Market is estimated to witness a CAGR of 8.5% during the forecast period 2017-2023. The Molecular Diagnostics market is analyzed based on four segments, namely application, technology, end-users, and regions.

Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the molecular diagnostics market followed by Europe. Various countries in the Americas are taking initiatives for the elimination of viral hepatitis and the major challenge remains in the diagnosis of this disease. This is providing an opportunity for the manufacturers to enhance their market presence. Asia Pacific is expected to have the fastest growth rate due to the high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by rest of the world, in terms of the growth rate during the forecast period.

Technology Analysis: Technologically, PCR is the primary technique performed before the start of any molecular diagnostic examination and is the golden standard technique for DNA amplification. Thus, the PCR technique holds the largest share among all the molecular diagnostic techniques. The advantages of microarray technology and its wide application range has made it the fastest growing segment in the market.

Application Analysis: The infectious diseases are the largest application segment in 2016 due to a large number of patients suffering with sexually transmitted diseases (STDs), hepatitis, hospital acquired infection, respiratory infection, pathogen ID detection, and others. The market for oncology is expected to have the fastest growth rate during the forecast period due to its rising prevalence of cancer globally.

Key Players: F. Hoffmann-la Roche, Hologic, Inc, Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, Bio-ad Laboratories, Inc, Qiagen NV, bioMerieux S.A, Thermo Fisher Scientific are the other predominate and niche players.

Competitive Analysis: Currently, the PCR market is dominating the global molecular diagnostics market, but a lot of new players are focusing on developing microarray and next-generation sequencing technologies to gain future business opportunities. Significant investments in R&D in this market is seen to develop novel technologies. As a support, many companies are receiving funds to develop advanced technology products from diagnostics associations and other venture capitalists. For instance, in November 2016, QuantuMDx received funding from the Bill & Melinda Gates Foundation to develop the CAPTURE-XT pathogen concentration technology and Q-POC molecular diagnostic platform for rapid low-cost TB detection and drug susceptibility testing (DST).

Benefits: The report provides complete details about the usage and adoption rate of molecular diagnostics in various therapeutic verticals and regions. Thus, the key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are impacting the market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture the revenue in these specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

 

 

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Outlook

1.1 Industry Overview

1.2 Industry Trends

1.3 PEST Analysis

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Total Addressable Market

3.2 Segmented Addressable Market

3.3 Related Markets

3.3.1 Immunoassays

3.3.2 Clinical Chemistry

4 Market Outlook

4.1 Market Definition-Infoholic Research

4.2 Market Segmentation

4.3 Porter 5(Five) Forces

5 Market Characteristics

5.1 Milestones in Molecular Diagnostics

5.2 Basic steps of molecular diagnostics

5.3 Market Dynamics

5.3.1 Drivers

5.3.1.1 Increasing prevalence of Infectious diseases

5.3.1.2 Growing adoption of POC testing

5.3.1.3 Increasing demand for biomarker-based tests

5.3.1.4 High growth of market in emerging countries

5.3.2 Opportunities

5.3.2.1 Growing significance of companion diagnostics

5.3.2.2 Increased number of Merger and Acquisition

5.3.2.3 Increased adoption of DNA probe-based diagnostics

5.3.3 Restraints

5.3.3.1 Stringent regulatory approvals

5.3.3.2 Lack of skilled labor

5.3.4 DRO-Impact Analysis

5.3.5 Key Stakeholders

6 Market Segmentation by Technology: Market Size and Analysis

6.1 Overview

6.2 Polymerase Chain Reaction (PCR)

6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

6.4 Microarray

6.5 Hybridization

6.6 DNA Sequencing

6.7 Other MDX technology

7 Market Segmentation by Application: Market Size and Analysis

7.1 Overview

7.2 Oncology

7.3 Blood Testing

7.4 Infectious Diseases

7.5 Genetic Testing

7.6 Tissue Typing

7.7 Others

8 End-user: Market Size and Analysis

8.1 Overview

8.2 Hospitals

8.3 Reference Laboratories

8.4 Others

9 Regions: Market Size and Analysis

9.1 Overview

9.2 North America

9.2.1 US 40

9.3 Europe

9.3.1 UK 41

9.3.2 Germany

9.4 APAC

9.4.1 India

9.4.2 China

9.4.3 Japan

9.5 Rest of the World

9.5.1 Brazil

9.5.2 Mexico

9.5.3 Africa

10 Competitive Landscape

10.1 Overview

11 Vendor Profiles

11.1 F.Hoffmann-La Roche Ltd

11.1.1 Overview

11.1.2 Business Unit

11.1.3 Geographic Presence

11.1.4 Business Focus

11.1.5 SWOT Analysis

11.1.6 Business Strategy

11.2 Abbott Laboratories

11.2.1 Overview

11.2.2 Business Unit

11.2.3 Geographic Presence

11.2.4 Business Focus

11.2.5 SWOT Analysis

11.2.6 Business Strategy

11.3 Siemens Healthineers Inc.

11.3.1 Overview

11.3.2 Geographic Presence

11.3.3 Business Focus

11.3.4 SWOT Analysis

11.3.5 Business Strategy

11.4 Danaher Corporation.

11.4.1 Overview

11.4.2 Business Unit

11.4.3 Geographic Presence

11.4.4 Business Focus

11.4.5 SWOT Analysis

11.4.6 Business Strategy

11.5 Hologic Inc.

11.5.1 Overview

11.5.2 Business Unit

11.5.3 Geographic Presence

11.5.4 Business Focus

11.5.5 SWOT Analysis

11.5.6 Business Strategy

12 Companies to Watch For

12.1 Becton Dickinson and Company

12.1.1 Overview

12.2 Bio-Rad Laboratories, Inc.

12.2.1 Overview

12.3 QIAGEN NV

12.3.1 Overview

12.4 bioMerieux S.A.

12.4.1 Overview

12.5 ThermoFisher Scientific.

12.5.1 Overview

Annexure

12.6 Abbreviations

 


List Of Figure

Charts

 

 

CHART 1 PEST ANALYSIS OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 13

CHART 2 RESEARCH METHODOLOGY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 15

CHART 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE, 2016-2023 (USD MILLION) 16

CHART 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENTATION 18

CHART 5 PORTER 5 FORCES ON GLOBAL MOLECULAR DIAGNOSTICS MARKET 19

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 21

CHART 7 DRO IMPACT ANALYSIS OF THE GLOBAL MOLECULAR DIAGNOSTICS MARKET 24

CHART 8 KEY STAKEHOLDERS 25

CHART 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY 2016 (% SHARE) 26

CHART 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2016 (% SHARE) 29

CHART 11 GLOBAL ONCOLOGY MARKET REVENUE, 2017-2023 (USD MILLION) 30

CHART 12 GLOBAL ONCOLOGY TYPES MARKET SHARE, 2016 (%) 31

CHART 13 GLOBAL BLOOD TESTING MARKET REVENUE, 2017-2023 (USD MILLION) 32

CHART 14 GLOBAL INFECTIOUS DISEASES MARKET REVENUE, 2017-2023 (USD MILLION) 33

CHART 15 GLOBAL INFECTIOUS DISEASES MARKET SHARE, 2016 (%) 33

CHART 16 GLOBAL GENETIC TESTING MARKET REVENUE FORECAST, 2017-2023 (USD MILLION) 34

CHART 17 GLOBAL TISSUE TYPING MARKET REVENUE, 2017-2023 (USD MILLION) 35

CHART 18 GLOBAL OTHERS MARKET REVENUE, 2017-2023 (USD MILLION) 36

CHART 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END-USER SEGMENTATION, 2016 (% SHARE) 37

CHART 20 GLOBAL MOLECULAR DIAGNOSTIC MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (% SHARE) 39

CHART 21 GLOBAL MOLECULAR DIAGNOSTIC MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (% SHARE) 40

CHART 22 MOLECULAR DIAGNOSTICS MARKET REVENUE IN THE NORTH AMERICA, 2016-2023 (USD MILLION) 41

CHART 23 MOLECULAR DIAGNOSTICS MARKET REVENUE IN EUROPE, 2016-2023 (USD MILLION) 42

CHART 24 MOLECULAR DIAGNOSTICS MARKET REVENUE IN APAC, 2016-2023 (USD MILLION) 44

CHART 25 MOLECULAR DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2016-2023 (USD MILLION) 46

CHART 26 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 58

CHART 27 F. HOFFMANN.LA ROCHE: BUSINESS UNITS 59

CHART 28 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE 60

CHART 29 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 61

CHART 30 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 65

CHART 31 ABBOTT LABORATORIES.: BUSINESS UNITS 66

CHART 32 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 67

CHART 33 ABBOTT LABORATORIES.: SWOT ANALYSIS 68

CHART 34 SIEMENS HEALTHINEERS INC.: OVERVIEW SNAPSHOT 72

CHART 35 SIEMENS HEALTHINEERS INC.: GEOGRAPHIC PRESENCE 73

CHART 36 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 74

CHART 37 DANAHER CORPORATION: OVERVIEW SNAPSHOT 78

CHART 38 DANAHER CORPORATION: BUSINESS UNITS 79

CHART 39 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 80

CHART 40 DANAHER CORPORATION: SWOT ANALYSIS 81

CHART 41 HOLOGIC INC.: OVERVIEW SNAPSHOT 85

CHART 42 HOLOGIC INC.: BUSINESS UNITS 86

CHART 43 HOLOGIC INC.: GEOGRAPHICAL PRESENCE 87

CHART 44 HOLOGIC INC.: SWOT ANALYSIS 88

 


List Of Table

Tables

 

TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 (USD MILLION) 28

TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE BY GEOGRAPHY, 2016-2023 (USD MILLION) 38

TABLE 3 OTHER PROMINENT VENDORS IN THE MARKET 47

TABLE 4 F. HOFFMANN-LA ROCHE: OFFERINGS 49

TABLE 5 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS 52

TABLE 6 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 60

TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 61

TABLE 8 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 67

TABLE 9 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 67

TABLE 10 DANAHER CORPORATION: OFFERINGS 73

TABLE 11 DANAHER CORPORATION: RECENT DEVELOPMENTS 74

TABLE 12 HOLOGIC INC: OFFERINGS 80

TABLE 13 HOLOGIC INC.: RECENT DEVELOPMENTS 82

TABLE 14 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS 88

TABLE 15 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 90

TABLE 16 QIAGEN NV: RECENT DEVELOPMENTS 91

TABLE 17 BIOMERIEUX: RECENT DEVELOPMENTS 93

TABLE 18 THERMOFISHER SCIENTIFIC: RECENT DEVELOPMENTS 94

 

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

F. Hoffmann-la Roche, Hologic, Inc, Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, Bio-ad Laboratories, Inc, Qiagen NV, bioMerieux S.A, Thermo Fisher Scientific are the other predominate and niche players

Global Molecular Diagnostics Market-Drivers, Opportunities, Trends, and Forecasts: 2017-2023

Overview: Molecular diagnostics includes the measurement and analysis of nucleic acids, proteins, and metabolites to study the genotypes and occurrence of any biochemical changes in the body. This is mainly used to examine disease occurrence in blood, tissue, or even in the bones. The importance of DNA in defining the vital cellular process has facilitated medical advancements in different disease diagnosis. The detection of cancer and various infectious diseases at an early stage is an important advantage of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in front line.

The market for molecular diagnostics is driven by the increasing prevalence of infectious diseases, growing adoption of point-of-care testing, increasing demand for biomarker-based test, and high growth of the market in emerging countries. The growing significance of companion diagnostics, increased number of M&A, and the increased adoption of DNA probe-based diagnostics are providing market growth opportunities. However, stringent regulatory approval and lack of skilled labors are hampering the market growth.

Market Analysis: The Global Molecular Diagnostics Market is estimated to witness a CAGR of 8.5% during the forecast period 2017-2023. The Molecular Diagnostics market is analyzed based on four segments, namely application, technology, end-users, and regions.

Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the molecular diagnostics market followed by Europe. Various countries in the Americas are taking initiatives for the elimination of viral hepatitis and the major challenge remains in the diagnosis of this disease. This is providing an opportunity for the manufacturers to enhance their market presence. Asia Pacific is expected to have the fastest growth rate due to the high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by rest of the world, in terms of the growth rate during the forecast period.

Technology Analysis: Technologically, PCR is the primary technique performed before the start of any molecular diagnostic examination and is the golden standard technique for DNA amplification. Thus, the PCR technique holds the largest share among all the molecular diagnostic techniques. The advantages of microarray technology and its wide application range has made it the fastest growing segment in the market.

Application Analysis: The infectious diseases are the largest application segment in 2016 due to a large number of patients suffering with sexually transmitted diseases (STDs), hepatitis, hospital acquired infection, respiratory infection, pathogen ID detection, and others. The market for oncology is expected to have the fastest growth rate during the forecast period due to its rising prevalence of cancer globally.

Key Players: F. Hoffmann-la Roche, Hologic, Inc, Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, Bio-ad Laboratories, Inc, Qiagen NV, bioMerieux S.A, Thermo Fisher Scientific are the other predominate and niche players.

Competitive Analysis: Currently, the PCR market is dominating the global molecular diagnostics market, but a lot of new players are focusing on developing microarray and next-generation sequencing technologies to gain future business opportunities. Significant investments in R&D in this market is seen to develop novel technologies. As a support, many companies are receiving funds to develop advanced technology products from diagnostics associations and other venture capitalists. For instance, in November 2016, QuantuMDx received funding from the Bill & Melinda Gates Foundation to develop the CAPTURE-XT pathogen concentration technology and Q-POC molecular diagnostic platform for rapid low-cost TB detection and drug susceptibility testing (DST).

Benefits: The report provides complete details about the usage and adoption rate of molecular diagnostics in various therapeutic verticals and regions. Thus, the key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are impacting the market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture the revenue in these specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

 

 

READ MORE

Scope

Table of Contents

1 Industry Outlook

1.1 Industry Overview

1.2 Industry Trends

1.3 PEST Analysis

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Total Addressable Market

3.2 Segmented Addressable Market

3.3 Related Markets

3.3.1 Immunoassays

3.3.2 Clinical Chemistry

4 Market Outlook

4.1 Market Definition-Infoholic Research

4.2 Market Segmentation

4.3 Porter 5(Five) Forces

5 Market Characteristics

5.1 Milestones in Molecular Diagnostics

5.2 Basic steps of molecular diagnostics

5.3 Market Dynamics

5.3.1 Drivers

5.3.1.1 Increasing prevalence of Infectious diseases

5.3.1.2 Growing adoption of POC testing

5.3.1.3 Increasing demand for biomarker-based tests

5.3.1.4 High growth of market in emerging countries

5.3.2 Opportunities

5.3.2.1 Growing significance of companion diagnostics

5.3.2.2 Increased number of Merger and Acquisition

5.3.2.3 Increased adoption of DNA probe-based diagnostics

5.3.3 Restraints

5.3.3.1 Stringent regulatory approvals

5.3.3.2 Lack of skilled labor

5.3.4 DRO-Impact Analysis

5.3.5 Key Stakeholders

6 Market Segmentation by Technology: Market Size and Analysis

6.1 Overview

6.2 Polymerase Chain Reaction (PCR)

6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

6.4 Microarray

6.5 Hybridization

6.6 DNA Sequencing

6.7 Other MDX technology

7 Market Segmentation by Application: Market Size and Analysis

7.1 Overview

7.2 Oncology

7.3 Blood Testing

7.4 Infectious Diseases

7.5 Genetic Testing

7.6 Tissue Typing

7.7 Others

8 End-user: Market Size and Analysis

8.1 Overview

8.2 Hospitals

8.3 Reference Laboratories

8.4 Others

9 Regions: Market Size and Analysis

9.1 Overview

9.2 North America

9.2.1 US 40

9.3 Europe

9.3.1 UK 41

9.3.2 Germany

9.4 APAC

9.4.1 India

9.4.2 China

9.4.3 Japan

9.5 Rest of the World

9.5.1 Brazil

9.5.2 Mexico

9.5.3 Africa

10 Competitive Landscape

10.1 Overview

11 Vendor Profiles

11.1 F.Hoffmann-La Roche Ltd

11.1.1 Overview

11.1.2 Business Unit

11.1.3 Geographic Presence

11.1.4 Business Focus

11.1.5 SWOT Analysis

11.1.6 Business Strategy

11.2 Abbott Laboratories

11.2.1 Overview

11.2.2 Business Unit

11.2.3 Geographic Presence

11.2.4 Business Focus

11.2.5 SWOT Analysis

11.2.6 Business Strategy

11.3 Siemens Healthineers Inc.

11.3.1 Overview

11.3.2 Geographic Presence

11.3.3 Business Focus

11.3.4 SWOT Analysis

11.3.5 Business Strategy

11.4 Danaher Corporation.

11.4.1 Overview

11.4.2 Business Unit

11.4.3 Geographic Presence

11.4.4 Business Focus

11.4.5 SWOT Analysis

11.4.6 Business Strategy

11.5 Hologic Inc.

11.5.1 Overview

11.5.2 Business Unit

11.5.3 Geographic Presence

11.5.4 Business Focus

11.5.5 SWOT Analysis

11.5.6 Business Strategy

12 Companies to Watch For

12.1 Becton Dickinson and Company

12.1.1 Overview

12.2 Bio-Rad Laboratories, Inc.

12.2.1 Overview

12.3 QIAGEN NV

12.3.1 Overview

12.4 bioMerieux S.A.

12.4.1 Overview

12.5 ThermoFisher Scientific.

12.5.1 Overview

Annexure

12.6 Abbreviations

 


List Of Figure

Charts

 

 

CHART 1 PEST ANALYSIS OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 13

CHART 2 RESEARCH METHODOLOGY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET 15

CHART 3 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE, 2016-2023 (USD MILLION) 16

CHART 4 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENTATION 18

CHART 5 PORTER 5 FORCES ON GLOBAL MOLECULAR DIAGNOSTICS MARKET 19

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 21

CHART 7 DRO IMPACT ANALYSIS OF THE GLOBAL MOLECULAR DIAGNOSTICS MARKET 24

CHART 8 KEY STAKEHOLDERS 25

CHART 9 GLOBAL MOLECULAR DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY 2016 (% SHARE) 26

CHART 10 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2016 (% SHARE) 29

CHART 11 GLOBAL ONCOLOGY MARKET REVENUE, 2017-2023 (USD MILLION) 30

CHART 12 GLOBAL ONCOLOGY TYPES MARKET SHARE, 2016 (%) 31

CHART 13 GLOBAL BLOOD TESTING MARKET REVENUE, 2017-2023 (USD MILLION) 32

CHART 14 GLOBAL INFECTIOUS DISEASES MARKET REVENUE, 2017-2023 (USD MILLION) 33

CHART 15 GLOBAL INFECTIOUS DISEASES MARKET SHARE, 2016 (%) 33

CHART 16 GLOBAL GENETIC TESTING MARKET REVENUE FORECAST, 2017-2023 (USD MILLION) 34

CHART 17 GLOBAL TISSUE TYPING MARKET REVENUE, 2017-2023 (USD MILLION) 35

CHART 18 GLOBAL OTHERS MARKET REVENUE, 2017-2023 (USD MILLION) 36

CHART 19 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY END-USER SEGMENTATION, 2016 (% SHARE) 37

CHART 20 GLOBAL MOLECULAR DIAGNOSTIC MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (% SHARE) 39

CHART 21 GLOBAL MOLECULAR DIAGNOSTIC MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (% SHARE) 40

CHART 22 MOLECULAR DIAGNOSTICS MARKET REVENUE IN THE NORTH AMERICA, 2016-2023 (USD MILLION) 41

CHART 23 MOLECULAR DIAGNOSTICS MARKET REVENUE IN EUROPE, 2016-2023 (USD MILLION) 42

CHART 24 MOLECULAR DIAGNOSTICS MARKET REVENUE IN APAC, 2016-2023 (USD MILLION) 44

CHART 25 MOLECULAR DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2016-2023 (USD MILLION) 46

CHART 26 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 58

CHART 27 F. HOFFMANN.LA ROCHE: BUSINESS UNITS 59

CHART 28 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE 60

CHART 29 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 61

CHART 30 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 65

CHART 31 ABBOTT LABORATORIES.: BUSINESS UNITS 66

CHART 32 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 67

CHART 33 ABBOTT LABORATORIES.: SWOT ANALYSIS 68

CHART 34 SIEMENS HEALTHINEERS INC.: OVERVIEW SNAPSHOT 72

CHART 35 SIEMENS HEALTHINEERS INC.: GEOGRAPHIC PRESENCE 73

CHART 36 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 74

CHART 37 DANAHER CORPORATION: OVERVIEW SNAPSHOT 78

CHART 38 DANAHER CORPORATION: BUSINESS UNITS 79

CHART 39 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 80

CHART 40 DANAHER CORPORATION: SWOT ANALYSIS 81

CHART 41 HOLOGIC INC.: OVERVIEW SNAPSHOT 85

CHART 42 HOLOGIC INC.: BUSINESS UNITS 86

CHART 43 HOLOGIC INC.: GEOGRAPHICAL PRESENCE 87

CHART 44 HOLOGIC INC.: SWOT ANALYSIS 88

 


List Of Table

Tables

 

TABLE 1 GLOBAL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2016-2023 (USD MILLION) 28

TABLE 2 GLOBAL MOLECULAR DIAGNOSTICS MARKET REVENUE BY GEOGRAPHY, 2016-2023 (USD MILLION) 38

TABLE 3 OTHER PROMINENT VENDORS IN THE MARKET 47

TABLE 4 F. HOFFMANN-LA ROCHE: OFFERINGS 49

TABLE 5 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS 52

TABLE 6 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 60

TABLE 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 61

TABLE 8 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 67

TABLE 9 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 67

TABLE 10 DANAHER CORPORATION: OFFERINGS 73

TABLE 11 DANAHER CORPORATION: RECENT DEVELOPMENTS 74

TABLE 12 HOLOGIC INC: OFFERINGS 80

TABLE 13 HOLOGIC INC.: RECENT DEVELOPMENTS 82

TABLE 14 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS 88

TABLE 15 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 90

TABLE 16 QIAGEN NV: RECENT DEVELOPMENTS 91

TABLE 17 BIOMERIEUX: RECENT DEVELOPMENTS 93

TABLE 18 THERMOFISHER SCIENTIFIC: RECENT DEVELOPMENTS 94

 

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

F. Hoffmann-la Roche, Hologic, Inc, Danaher Corporation, Abbott Laboratories, and Siemens Healthineers Inc. are the key players in the market. Becton Dickenson and Company, Bio-ad Laboratories, Inc, Qiagen NV, bioMerieux S.A, Thermo Fisher Scientific are the other predominate and niche players

chat_bubbleLet's Chat